Where this ovarian cancer information comes from | Cancer Research UK
Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter

Where this ovarian cancer information comes from

Women discussing ovarian cancer

This page tells you about the major sources of information that we used to put together the ovarian cancer section.

 

About CancerHelp UK information

All our information is checked by cancer specialists and surgeons who specialise in treating cancer. The names of our specialist reviewers are at the end of this list. We also try to find patients to review all our sections. If you have had ovarian cancer, live in the UK and would like to become a patient reviewer, you can write to us by clicking on contact us.

 

Websites

Cancer Research UK
CancerStats

US National Cancer Institute
Information on the treatment of ovarian cancer
www.cancer.gov/cancertopics/types/ovarian

 

Books

Principles and practice of oncology (10th edition)
De Vita VT, Lawrence TS and Rosenberg SA
Lippincott, Williams and Wilkins, 2015

Cancer and its management (7th edition)
Tobias J. and Hochhauser D.
Wiley-Blackwell, 2015

Textbook of Uncommon Cancer (4th edition)
Raghavan D, Blanke C, Johnson D et al
Wiley-Blackwell, 2012

 

UK guidelines

The recognition and initial management of ovarian cancer.
The National Institute for Health and Care Excellence (NICE), April 2011
Link to the NICE website

Epithelial Ovarian Cancer
Scottish Intercollegiate Guidelines Network (SIGN), November 2013
Link to the SIGN website

Bevacizumab in combination with paclitaxel and carboplatin for first line treatment of advanced ovarian cancer
The National Institute of Health and Care Excellence (NICE), May 2013
Link to the NICE website

Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum sensitive advanced ovarian cancer
The National Institute of Health and Care Excellence (NICE, May 2013
Link to the NICE website

Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for the treatment of advanced ovarian cancer.
The National Institute for Health and Care Excellence (NICE), May 2005
Link to the NICE website

Guidance on the use of paclitaxel for ovarian cancer. NICE.
The National Institute for Health and Care Excellence (NICE), January 2003
Link to the NICE website

Ovarian cysts in postmenopausal women
Royal College of Obstetricans and Gynaecologists
Guideline No 34, Oct 2003

Bevacizumab in combination with carboplatin and paclitaxel for the front-line treatment of advanced (International Federation of Gynaecology and Obstetrics [FIGO] stages III B, III C and IV) epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Scottish Medicines Consortium, September 2012, SMC No. (806/12)
Link to SMC website

 

Articles and reviews

Newly diagnosed and relapsed epithelial ovarian carcinoma:ESMO clinical practice guidelines for diagnosis, treatment and follow up. Annals of oncology 2013. 24 (suppl 6): Vi24 - vi 32

Ovarian cancer. Gordon C Jayson and others. The Lancet, October 11 2014. Vol 384, 1376-88. 

Ovarian cancer screening and mortality in the UK (UKCTOCS): a randomised controlled trial. Ian J Jacobs and others. The Lancet, March 5 2016. 387:945-56.

Results of annual screening in phase 1 of the United Kingdom Familial Ovarian Cancer Study highlight the need for strict adherence to screening schedule. Journal of Clinical Oncology. 2013. 31 (1): 49 - 57

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). The Lancet 2009 10(4): 321-40

Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer. Morrison J, Haldar K, Kehoe S et al. Cochrane Database of Systematic Reviews, 2012

Ovarian cancer and hormone replacement therapy in the Million Women Study. Million Women Study Collaborators. The Lancet 2007;369: 1703-10.

Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer. Jaaback K, Johnson N. and Lawrie T. Cochrane Database of Systematic Reviews, 2011.

Interval debulking surgery for advanced epithelial ovarian cancer. Tangjitgamol S, Manusirivithaya S, Laopaiboon M, Lumbiganon P. Cochrane Database of Systematic Reviews, 2013

Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer. Winter-Roach BA, Kitchener HC, Dickinson HO. Cochrane Database of Systematic Reviews, 2009

 

Specialist reviewers

Professor Jonathan Ledermann, Professor of medical oncology
Mr Robin Crawford, Gynaecological oncologist (MD, FRCS, MRCOG)
Beverley, Patient reviewer
Adele, Patient reviewer

 

Diagrams

Dee McLean - MeDee Art, Medical Illustrations

Rate this page:
Submit rating
Rate this page
Rate this page for no comments box
Please enter feedback to continue submitting
Send feedback
Question about cancer? Contact our information nurse team

No Error

Updated: 27 April 2016